Sara McCoy, MD, PhD, RhMSUS

University of Wisconsin
Middleton, WI, United States

Dr. Sara McCoy graduated from Case Western Reserve School of Medicine in 2006 and completed her post-graduate medical training in Internal Medicine at Mayo Clinic and Rheumatology at the University of Michigan. Dr. McCoy has been a faculty member at the University of Wisconsin since 2015 and earned her PhD in 2021. Dr. McCoy created the University of Wisconsin Sjӧgren’s Clinic in 2016 and the Sjӧgren’s biorepository in 2017. Her research critically informs the pathogenesis of Sjӧgren’s disease, with a focus on salivary gland mesenchymal stromal cell immunobiology. She also is working to discover novel autoantibodies in Sjӧgren’s disease.

Presentation(s):

• How to Start a Disease Specific Registry/Clinic

  Friday, November 10, 2023
  3:45 PM – 4:05 PM PT

  Disclosure(s): Bristol-Myers Squibb(BMS): Consultant (Ongoing); Horizon: Consultant (Ongoing); Kiniksa: Consultant (Ongoing); Novartis: Consultant (Ongoing); Otsuka/Visterra: Consultant (Ongoing); Target RWE: Consultant (Ongoing)

• How to Start a Disease Specific Registry/Clinic

  Friday, November 10, 2023
  4:05 PM – 4:25 PM PT

  Disclosure(s): Bristol-Myers Squibb(BMS): Consultant (Ongoing); Horizon: Consultant (Ongoing); Kiniksa: Consultant (Ongoing); Novartis: Consultant (Ongoing); Otsuka/Visterra: Consultant (Ongoing); Target RWE: Consultant (Ongoing)

• How to Start a Disease Specific Registry/Clinic

  Friday, November 10, 2023
  4:25 PM – 4:45 PM PT

  Disclosure(s): Bristol-Myers Squibb(BMS): Consultant (Ongoing); Horizon: Consultant (Ongoing); Kiniksa: Consultant (Ongoing); Novartis: Consultant (Ongoing); Otsuka/Visterra: Consultant (Ongoing); Target RWE: Consultant (Ongoing)

• How to Start a Disease Specific Registry/Clinic

  Friday, November 10, 2023
  4:45 PM – 5:05 PM PT

  Disclosure(s): Bristol-Myers Squibb(BMS): Consultant (Ongoing); Horizon: Consultant (Ongoing); Kiniksa: Consultant (Ongoing); Novartis: Consultant (Ongoing); Otsuka/Visterra: Consultant (Ongoing); Target RWE: Consultant (Ongoing)

• How to Start a Disease Specific Registry/Clinic

  Friday, November 10, 2023
  5:05 PM – 5:25 PM PT

  Disclosure(s): Bristol-Myers Squibb(BMS): Consultant (Ongoing); Horizon: Consultant (Ongoing); Kiniksa: Consultant (Ongoing); Novartis: Consultant (Ongoing); Otsuka/Visterra: Consultant (Ongoing); Target RWE: Consultant (Ongoing)

• 0010: A Potential Mechanism for Major Adverse Cardiac Events Associated with JAK Inhibitors: JAK Inhibitor Withdrawal Causes Urokinase Release by Primed STAT Signaling

  Sunday, November 12, 2023
  9:00 AM – 11:00 AM PT

  Disclosure(s): Bristol-Myers Squibb(BMS): Consultant (Ongoing); Horizon: Consultant (Ongoing); Kiniksa: Consultant (Ongoing); Novartis: Consultant (Ongoing); Otsuka/Visterra: Consultant (Ongoing); Target RWE: Consultant (Ongoing)

• 1367: Novel Autoantibodies Might Circumvent the Need for Labial Biopsy in a Subset of Seronegative Sjögren’s Disease Patients

  Monday, November 13, 2023
  9:00 AM – 11:00 AM PT

  Disclosure(s): Bristol-Myers Squibb(BMS): Consultant (Ongoing); Horizon: Consultant (Ongoing); Kiniksa: Consultant (Ongoing); Novartis: Consultant (Ongoing); Otsuka/Visterra: Consultant (Ongoing); Target RWE: Consultant (Ongoing)

• 13M156: Challenging Complications of the Nervous System in Sjögren's Syndrome

  Monday, November 13, 2023
  4:00 PM – 5:00 PM PT

  Disclosure(s): Bristol-Myers Squibb(BMS): Consultant (Ongoing); Horizon: Consultant (Ongoing); Kiniksa: Consultant (Ongoing); Novartis: Consultant (Ongoing); Otsuka/Visterra: Consultant (Ongoing); Target RWE: Consultant (Ongoing)